Search
Ketorolac
go.drugbank.com/drugs/DB00465ApprovedInvestigationalKetorolac is a Non-steroidal anti-inflammatory drug (NSAID) and is commercially available as an oral tablet, injectable, nasal spray and as an ophthalmic solution. … [L6520] Impressively, ketorolac has a similar efficacy to standard doses of morphine and meperidine making it a useful opioid sparing agent.[L6511]
Mixtures: MAVIDOL KCategories: Anti-Inflammatory Agents, Non-Steroidal (Non-Selective), Analgesics, Non-NarcoticSymptomatic for no more than 48 hours.
go.drugbank.com/conditions/DBCOND0116964Drugs: OseltamivirSynonyms: Symptomatic for no more than 48 hours, Symptomatic for no more than 48 hours.Witch hazel
go.drugbank.com/drugs/DB11111ApprovedInvestigationalNutraceuticalMixtures: Inotyol - Salbe, Bottoms Up HealthProducts: Leaders Daily Wonders You Say Dry I Say No More, Tension No. 5Von Willebrand factor human
go.drugbank.com/drugs/DB13133ApprovedInvestigational[L1878] A recombinant form of vWF, [vonicog alfa], is also available to enhance production and avoid the theoretical risk of pathogen transmission from plasma donors.[A32262] … [A32262] Exogenous sources of vWF are used to restore functional levels of vWF in blood disorders associated with deficient or abnormal blood clotting.
Mixtures: OPTIVATE(R), VONCENTO 1000 UI/ 2400 UICategories: von Willebrand factor and coagulation factor VIII in combinationButylscopolamine
go.drugbank.com/drugs/DB09300ApprovedInvestigationalVet approvedIt is used to treat pain and discomfort caused by abdominal cramps, menstrual cramps, or other spasmodic activity in the digestive system. It is also effective at preventing bladder spasms. … It is not a pain medication in the normal sense, since it does not directly affect pain, but rather works to prevent painful cramps and spasms from occurring.
Mixtures: BIPASMIN COMPUESTO N, BIPASMIN COMPUESTO NCategories: Drugs for Functional Gastrointestinal DisordersSevelamer
go.drugbank.com/drugs/DB00658ApprovedInvestigationalSevelamer is a phosphate binding drug used to prevent hyperphosphataemia in patients with chronic renal failure. It is marketed by Genzyme under the trade name Renagel.
Categories: Compounds used in a research, industrial, or household setting, Drugs for Treatment of Hyperkalemia and HyperphosphatemiaProducts: Sevelamer Carbonate for Oral Suspension, Sevelamer Carbonate For Oral SuspensionAmphotericin B
go.drugbank.com/drugs/DB00681ApprovedInvestigational1.0 mcg/mL in vitro. … The antibiotic is without effect on bacteria, rickettsiae, and viruses.
Categories: Compounds used in a research, industrial, or household setting, Antimycotics for Systemic UseProducts: AMPHOTRET FOR INJECTION USP 50MG, Amphotericin B for Injection, USPTeicoplanin
go.drugbank.com/drugs/DB06149ApprovedInvestigationalWithdrawnAll teicoplanins share a same glycopeptide core, teicoplanin A3-1, but differ in the length and conformation of side chains attached to their β-D-glucosamine moiety. … Teicoplanin is a glycopeptide antibiotic consisting of a mixture of several compounds, five major (named teicoplanin A2-1 through A2-5) and four minor (named teicoplanin RS-1 through RS-4).
Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseProducts: TARGOCID 200mg POWDER FOR SOLUTION FOR INJECTION/INFUSION, Ticplat 200 (Teicoplanin 200mg powder for solution for injection or infusion)Ganirelix
go.drugbank.com/drugs/DB06785ApprovedInvestigationalGanirelix is indicated for controlled ovarian hyperstimulation in assisted reproduction techniques. … [L43045] The first case of pregnancy achieved after the use of ganirelix in an assisted reproduction program was reported in 1998.[A252195] Ganirelix was first approved by the FDA on July 29, 1999.
Products: ORGALUTRAN SOLUTION FOR INJECTION 0.25 mg/0.5 ml, ORGALUTRAN 0.25MG/0.5ML (SOLUTION FOR INJECTION)Certolizumab pegol
go.drugbank.com/drugs/DB08904ApprovedInvestigational[A176606] It was developed and manufactured by UCB Pharma, first FDA approved in 2008[L45018] and updated for a new indication on March 28, 2019.[L5819] … [A176606] Certolizumab does not require glycosylation for active function and hence, its production is significantly more affordable when compared to other existing TNF-alpha therapies as it can be
Categories: Biologics for Rheumatoid Arthritis TreatmentProducts: CIMZIA 200 MG ILO IN FER, CIMZIA 200MG ILO IN FER